XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Noncontrolling Interest [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2023 $ 1,782,277   $ 0 $ 60 $ 2,909,757 $ (1,126,467) $ (1,073)
Beginning Balance, Shares at Dec. 31, 2023     0 603,128,781      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2023   $ 16,584          
Stock-based compensation expense 44,971       44,971    
Exercise of stock options 8,822       8,822    
Exercise of stock options, Shares       3,346,599      
Issuance of common stock under employee stock purchase plan, Value 1,833       1,833    
Issuance of common stock under employee stock purchase plan, Shares       194,307      
Issuance of common stock upon vesting of RSUs-net of tax (52,580)     $ 1 (52,581)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       7,588,048      
Accretion of redeemable non-controlling interest   1,142          
Accretion of redeemable non-controlling interest (1,142)       (1,142)    
Foreign currency translation adjustment (75)           (75)
Net (loss) income (597)         (597)  
Ending Balance at Mar. 31, 2024 1,783,509   $ 0 $ 61 2,911,660 (1,127,064) (1,148)
Ending Balance, Shares at Mar. 31, 2024     0 614,257,735      
Redeemable Non-Controlling Interest, Ending balance at Mar. 31, 2024   17,726          
Beginning Balance at Dec. 31, 2023 1,782,277   $ 0 $ 60 2,909,757 (1,126,467) (1,073)
Beginning Balance, Shares at Dec. 31, 2023     0 603,128,781      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2023   16,584          
Accretion of redeemable non-controlling interest 3,683            
Foreign currency translation adjustment 26            
Net (loss) income 24,980            
Ending Balance at Sep. 30, 2024 1,940,119   $ 0 $ 63 3,042,590 (1,101,487) (1,047)
Ending Balance, Shares at Sep. 30, 2024     0 625,325,706      
Redeemable Non-Controlling Interest, Ending balance at Sep. 30, 2024   20,267          
Beginning Balance at Dec. 31, 2023 1,782,277   $ 0 $ 60 2,909,757 (1,126,467) (1,073)
Beginning Balance, Shares at Dec. 31, 2023     0 603,128,781      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2023   16,584          
Ending Balance at Dec. 31, 2024 1,997,823   $ 0 $ 63 3,094,182 (1,095,227) (1,195)
Ending Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2024   21,679          
Beginning Balance at Mar. 31, 2024 1,783,509   $ 0 $ 61 2,911,660 (1,127,064) (1,148)
Beginning Balance, Shares at Mar. 31, 2024     0 614,257,735      
Redeemable Non-Controlling Interest, Beginning balance at Mar. 31, 2024   17,726          
Stock-based compensation expense 40,125       40,125    
Exercise of stock options 12,824     $ 1 12,823    
Exercise of stock options, Shares       4,518,651      
Issuance of common stock upon vesting of RSUs-net of tax (142)       (142)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       209,515      
Warrant redemption 37,122       37,122    
Warrant redemption, Shares       3,809,200      
Accretion of redeemable non-controlling interest   1,221          
Accretion of redeemable non-controlling interest (1,221)       (1,221)    
Foreign currency translation adjustment (16)           (16)
Net (loss) income 21,445         21,445  
Ending Balance at Jun. 30, 2024 1,893,646   $ 0 $ 62 3,000,367 (1,105,619) (1,164)
Ending Balance, Shares at Jun. 30, 2024     0 622,795,101      
Redeemable Non-Controlling Interest, Ending balance at Jun. 30, 2024   18,947          
Stock-based compensation expense 42,125       42,125    
Exercise of stock options 2,303       2,303    
Exercise of stock options, Shares       878,686      
Issuance of common stock under employee stock purchase plan, Value 3,912       3,912    
Issuance of common stock under employee stock purchase plan, Shares       414,584      
Issuance of common stock upon vesting of RSUs-net of tax (4,796)     $ 1 (4,797)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       1,237,335      
Accretion of redeemable non-controlling interest 1,320 1,320          
Accretion of redeemable non-controlling interest (1,320)       (1,320)    
Foreign currency translation adjustment 117           117
Net (loss) income 4,132         4,132  
Ending Balance at Sep. 30, 2024 1,940,119   $ 0 $ 63 3,042,590 (1,101,487) (1,047)
Ending Balance, Shares at Sep. 30, 2024     0 625,325,706      
Redeemable Non-Controlling Interest, Ending balance at Sep. 30, 2024   20,267          
Beginning Balance at Dec. 31, 2024 1,997,823   $ 0 $ 63 3,094,182 (1,095,227) (1,195)
Beginning Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2024   21,679          
Stock-based compensation expense 61,048       61,048    
Exercise of stock options 956       956    
Exercise of stock options, Shares       330,413      
Issuance of common stock under employee stock purchase plan, Value 1,650       1,650    
Issuance of common stock under employee stock purchase plan, Shares       174,906      
Issuance of common stock upon vesting of RSUs-net of tax $ (43,471)     $ 1 (43,472)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       9,095,994      
Issuance of restricted stock awards for business acquisition 10,356,096     792,174      
Issuance of common stock for business acquisition [1] $ 250,441     $ 3 250,438    
Issuance of common stock for business acquisition, shares [1]       26,035,603      
Repurchase and retirement of common stock (72,275)     $ (1)   (72,274)  
Repurchase and retirement of common stock, shares       (7,000,000)      
Accretion of redeemable non-controlling interest   1,276          
Reclassification of redeemable non-controlling interest to note payable to minority investor   (22,955)          
Accretion of redeemable non-controlling interest (1,276)       (1,276)    
Foreign currency translation adjustment (15)           (15)
Net (loss) income (17,421)         (17,421)  
Ending Balance at Mar. 31, 2025 2,177,460   $ 0 $ 66 3,363,526 (1,184,922) (1,210)
Ending Balance, Shares at Mar. 31, 2025     0 658,636,205      
Redeemable Non-Controlling Interest, Ending balance at Mar. 31, 2025   0          
Beginning Balance at Dec. 31, 2024 1,997,823   $ 0 $ 63 3,094,182 (1,095,227) (1,195)
Beginning Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2024   21,679          
Accretion of redeemable non-controlling interest 1,276            
Foreign currency translation adjustment 121            
Net (loss) income (6,432)            
Ending Balance at Sep. 30, 2025 2,129,822   $ 0 $ 65 3,449,971 (1,319,140) (1,074)
Ending Balance, Shares at Sep. 30, 2025     0 647,182,603      
Redeemable Non-Controlling Interest, Ending balance at Sep. 30, 2025   0          
Beginning Balance at Mar. 31, 2025 2,177,460   $ 0 $ 66 3,363,526 (1,184,922) (1,210)
Beginning Balance, Shares at Mar. 31, 2025     0 658,636,205      
Redeemable Non-Controlling Interest, Beginning balance at Mar. 31, 2025   0          
Stock-based compensation expense 45,975       45,975    
Exercise of stock options 1,003       1,003    
Exercise of stock options, Shares       360,029      
Issuance of common stock upon vesting of RSUs-net of tax (881)       (881)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       986,566      
Repurchase and retirement of common stock (100,220)     $ (1)   (100,219)  
Repurchase and retirement of common stock, shares       (10,988,327)      
Foreign currency translation adjustment 53           53
Net (loss) income 12,960         12,960  
Ending Balance at Jun. 30, 2025 2,136,350   $ 0 $ 65 3,409,623 (1,272,181) (1,157)
Ending Balance, Shares at Jun. 30, 2025     0 648,994,473      
Redeemable Non-Controlling Interest, Ending balance at Jun. 30, 2025   0          
Stock-based compensation expense 39,193       39,193    
Exercise of stock options 1,671       1,671    
Exercise of stock options, Shares       548,441      
Issuance of common stock under employee stock purchase plan, Value 3,394       3,394    
Issuance of common stock under employee stock purchase plan, Shares       424,270      
Issuance of common stock upon vesting of RSUs-net of tax (3,910)     $ 0 (3,910)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       1,994,729      
Repurchase and retirement of common stock (44,988)         (44,988)  
Repurchase and retirement of common stock, shares       (4,779,310)      
Accretion of redeemable non-controlling interest 0            
Foreign currency translation adjustment 83           83
Net (loss) income (1,971)         (1,971)  
Ending Balance at Sep. 30, 2025 $ 2,129,822   $ 0 $ 65 $ 3,449,971 $ (1,319,140) $ (1,074)
Ending Balance, Shares at Sep. 30, 2025     0 647,182,603      
Redeemable Non-Controlling Interest, Ending balance at Sep. 30, 2025   $ 0          
[1] Issuance of common stock for business acquisition includes 10,356,096 of restricted shares of common stock subject to re-vesting requirements (see Note 17).See notes to condensed consolidated financial statements.